TITLE

RAPID AND SUSTAINED SYMPTOM RELIEF WITH ON- DEMAND RAREPRAZOLE TREATMENT IN PATIENTS WITH NON-EROSIVE REFLUX DISEASE

AUTHOR(S)
Kennerley, P.; Bytzer, P.; Blum, A. L.
PUB. DATE
April 2004
SOURCE
Gut;Apr2004 Supplement 3, Vol. 53, pA61
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article presents a study of rapid and sustained symptom relief with on-demand rabeprazole treatment in patients with non-erosive reflux disease. In previous placebo (PBO) controlled studies, daily treatment with both rabeprazole (RAB) 10 and 20 mg resulted in a rapid time to first heartburn (HB) free interval in non-erosive reflux disease (NERD) patients. Rapid symptom relief is key in on-demand maintenance regimens. This multicentre, European trial assessed the efficacy of RAB 10 mg versus PBO in on-demand maintenance treatment. On-demand treatment with RAB achieved rapid and sustained symptom relief and reduced antacid use in patients with NERD.
ACCESSION #
13219049

 

Related Articles

  • A pharmacist's guide to heartburn therapy. Peleqrin, Grete M. // Pharmacy Today;Oct2004 Supplement, Vol. 10, p20 

    The article discusses heartburn with the help of over-the-counter drugs. Heartburn afflicts millions of Americans and is the hallmark of gastroesophageal rellux disease and erosive esophagilis. However, the angina like pain often caused by heartburn can be related to a more serious problem. OTC...

  • ASK THE EXPERTS.  // Natural Health;Dec/Jan2005, Vol. 34 Issue 11, p24 

    This article discusses several remedies to prevent heart burn. If an individual frequently suffers from heartburn, he should try wearing loosefitting clothes because tight clothes worsen the condition by putting pressure on the stomach, Don't eat less then two or three hours before one goes to...

  • Heartburn.  // American Family Physician;11/15/2003, Vol. 68 Issue 10, p2033 

    Provides information on heartburn. Definition; Causes; Tips on stopping heartburn.

  • Your doctor is in. Manson, Joann E. // Glamour;Apr2006, Vol. 104 Issue 4, p142 

    The article provides information about heartburn. Overweight individuals are more prone to the disease. A heartburn is also caused by going to bed fewer than three hours after a meal. This symptom must not be ignored since it can signal gastroesophageal reflux disease. Despite the availability...

  • Got Heartburn? Bannan, Karen J. // Good Housekeeping;Jan2004, Vol. 238 Issue 1, p71 

    Presents information on heartburn. Causes of heartburn; Features of heartburn; Medications recommended to treat heartburn.

  • Arbaclofen Placarbil in GERD: A Randomized, Double-Blind, Placebo-Controlled Study. Vakil, Nimish B.; Huff, F. Jacob; Bian, Amy; Jones, Drew S.; Stamler, David // American Journal of Gastroenterology;Aug2011, Vol. 106 Issue 8, p1427 

    OBJECTIVES:It has been shown that arbaclofen placarbil (AP) inhibits reflux in gastroesophageal reflux disease (GERD) following single oral dosing. This study evaluated the efficacy and safety of AP over 4 weeks in subjects with symptomatic GERD.METHODS:One hundred fifty-six subjects with...

  • Cholinergic Therapy of Chronic Heartburn. Farrell, Raymond; Roling, Gerald; Castell, Donald // Annals of Internal Medicine;May74, Vol. 80 Issue 5, p573 

    Reports on the results of a study using oral bethanechol and placebo in the treatment of patients with chronic heartburn. Major factor in the pathophysiology of gastroesophageal reflux; Materials and methods used in the study; Effect of bethanecol or placebo in producing symptomatic improvement.

  • BURN out. MURRAY, MICHREL T. // Better Nutrition;Sep2011, Vol. 73 Issue 9, p26 

    The article presents an overview of the human digestive process and discusses factors which can lead to indigestion. A discussion of several dietary supplements which can be used to aid digestion, including Dr. Venessa's Formulas Digestion Balance supplements, Enzymedica Acid Soothe supplements...

  • Development and psychometric evaluation of the patient assessment of upper gastrointestinal symptom severity index (PAGI-SYM) in patients with upper gastrointestinal disorders. Rentz, A.M.; Kahrilas, P.; Stanghellini, V.; Tack, J.; Taiiey, N.J.; De Ia Loge, C.; Trudeau, E.; Dubois, D.; Revicki, D.A. // Quality of Life Research;Dec2004, Vol. 13 Issue 10, p1739 

    Objective: Describe the development and evaluation of a new self-report instrument, the patient assessment of upper gastrointestinal disorders-symptom severity index (PAGI-SYM) in subjects with gastroesophageal reflux disease (GERD), dyspepsia, or gastroparesis. Methods: Recruited subjects with...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics